Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Guillaume Bonnefois"'
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 4, Pp 942-953 (2022)
Abstract The recently released revised vancomycin consensus guideline endorsed area under the concentration‐time curve (AUC) guided monitoring. Means to AUC‐guided monitoring include pharmacokinetic (PK) equations and Bayesian software programs,
Externí odkaz:
https://doaj.org/article/97bb6b8a51794810a200517ebbea8b2c
Autor:
Imad Kassem, Steven Sanche, Jun Li, Guillaume Bonnefois, Marie‐Pierre Dubé, Jean‐Lucien Rouleau, Jean‐Claude Tardif, Michel White, Jacques Turgeon, Fahima Nekka, Simon deDenus
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 1, Pp 194-203 (2021)
Heart failure (HF) causes pathological changes in multiple organs, thus affecting the pharmacokinetics (PK) of drugs. The aim of this study was to investigate the PK of candesartan in patients with HF while examining significant covariates and their
Externí odkaz:
https://doaj.org/article/06648dc786d34810be9652d22f425824
Autor:
Nassim Djebli, Pierre-Olivier Tremblay, Vincent Buchheit, Mario González-Sales, Guillaume Bonnefois, Georgina Meneses-Lorente, Francois Mercier, Nicolas Frey
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:997-1007
Entrectinib (ROZLYTREK®) is a CNS-active, potent, and selective inhibitor of ROS1, TRK A/B/C, and ALK kinase activity. It was recently approved for the treatment of ROS1-positive non-small cell lung cancer and NTRK gene fusion-positive solid tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f87e74e53084d6841bca6a353f37168
https://doi.org/10.1007/s00280-021-04353-8
https://doi.org/10.1007/s00280-021-04353-8
Autor:
Marie-Pierre Dubé, Jean-Claude Tardif, Jun Li, Jean-Lucien Rouleau, Fahima Nekka, Steven Sanche, Guillaume Bonnefois, Michel White, Imad Kassem, Simon de Denus, Jacques Turgeon
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 1, Pp 194-203 (2021)
Clinical and Translational Science, Vol 14, Iss 1, Pp 194-203 (2021)
Heart failure (HF) causes pathological changes in multiple organs, thus affecting the pharmacokinetics (PK) of drugs. The aim of this study was to investigate the PK of candesartan in patients with HF while examining significant covariates and their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61559236ee9969dd19aceba930c81c02
http://europepmc.org/articles/PMC7877833
http://europepmc.org/articles/PMC7877833
Publikováno v:
Clinical and translational science. 15(4)
The recently released revised vancomycin consensus guideline endorsed area under the concentration-time curve (AUC) guided monitoring. Means to AUC-guided monitoring include pharmacokinetic (PK) equations and Bayesian software programs, with the latt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e07d52e39aed955fbff9089e063b23f3
https://pubmed.ncbi.nlm.nih.gov/35170243
https://pubmed.ncbi.nlm.nih.gov/35170243
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 49(2)
To evaluate study designs and the influence of dispersion of body size, body composition and maturation of clearance or reliable estimation of allometric exponents. Non-linear mixed effects modeling and parametric bootstrap were employed to assess ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16665beb094fdad1adecabd51dfa1a98
https://pubmed.ncbi.nlm.nih.gov/34609707
https://pubmed.ncbi.nlm.nih.gov/34609707
Autor:
Nathalie H. Gosselin, Ulf Landmesser, Guillaume Bonnefois, Patrick F. Smith, Gregory S. Schwartz, Frederick J. Raal, Lorena Garcia Conde, Kausik K. Ray, Lawrence A. Leiter, R. Scott Wright, Wolfgang Koenig, David Kallend, Laura H Gunn
Publikováno v:
Journal of the American College of Cardiology. 77:1462
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3105b47521972a97c7e86087da96090f
https://doi.org/10.1016/s0735-1097(21)02820-5
https://doi.org/10.1016/s0735-1097(21)02820-5
Autor:
Mario González-Sales, Pierre Olivier Tremblay, Guillaume Bonnefois, Fahima Nekka, Olivier Barrière, Julie Desrochers
Publikováno v:
The R Journal. 12:107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::050a49bdc62cab01f5f37df231069031
https://doi.org/10.32614/rj-2021-006
https://doi.org/10.32614/rj-2021-006
Publikováno v:
Mathematics in Industry ISBN: 9783319234120
Individualized dose adaptation usually requires Therapeutic Drug Monitoring (TDM) based on patient blood samplings. However this invasive approach, generally accompanied with discomfort and cost, is not always justified since it may occur that the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::703ab41dd139284680f9567c671acbc1
https://doi.org/10.1007/978-3-319-23413-7_141
https://doi.org/10.1007/978-3-319-23413-7_141
